Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Wolbrette

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cardiac Electrophysiology Clinics|August 4, 2017
Antiarrhythmic Drugs: Age, Race, and Gender EffectsDeborah Wolbrette
Current Women'S Health Reports|July 16, 2002
Gender differences in the proarrhythmic potential of QT-prolonging drugsDeborah Wolbrette
Current Women'S Health Reports|March 12, 2003
Treatment of arrhythmias during pregnancyDeborah Wolbrette
Clinical Cardiology|February 14, 2002
Gender differences in arrhythmiasDeborah Wolbrette, Gerald Naccarelli, Anne Curtis, et al.
Vascular Health and Risk Management|August 24, 2010
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacyDeborah Wolbrette, Mario Gonzalez, Soraya Samii, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 25, 2016
Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillationAnene Ukaigwe, Pragya Shrestha, Paras Karmacharya, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cardiac Electrophysiology Clinics|August 4, 2017
Antiarrhythmic Drugs: Age, Race, and Gender EffectsDeborah Wolbrette
Current Women'S Health Reports|July 16, 2002
Gender differences in the proarrhythmic potential of QT-prolonging drugsDeborah Wolbrette
Current Women'S Health Reports|March 12, 2003
Treatment of arrhythmias during pregnancyDeborah Wolbrette
Clinical Cardiology|February 14, 2002
Gender differences in arrhythmiasDeborah Wolbrette, Gerald Naccarelli, Anne Curtis, et al.
Vascular Health and Risk Management|August 24, 2010
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacyDeborah Wolbrette, Mario Gonzalez, Soraya Samii, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 25, 2016
Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillationAnene Ukaigwe, Pragya Shrestha, Paras Karmacharya, et al.
Pageof 1